ArticleBlood2016

The BCL2 selective inhibitor venetoclax induces rapid onset apoptosis of CLL cells in patients via a TP53-independent mechanism.

Mary Ann Anderson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.